FDA Recently Approved Two Orphan Drugs
December 27, 2012-- FDA recently announced the approval of two new Orphan Drugs.
FDA has approved Gattex as a treatement for adults with short bowel syndrome who need additional nutrition through IV feeding. More >
FDA has approved Juxtapid to reduce low-density lipoprotein (LDL) cholesterol, total cholesterol, apolipoprotein B, and non-high-density lipoprotein (non-HDL) cholesterol in patients with homozygous familial hypercholesterolemia (HoFH). More >